0001209191-23-018385.txt : 20230314 0001209191-23-018385.hdr.sgml : 20230314 20230314141350 ACCESSION NUMBER: 0001209191-23-018385 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230310 FILED AS OF DATE: 20230314 DATE AS OF CHANGE: 20230314 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Yacob Ezra Y CENTRAL INDEX KEY: 0001724997 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09743 FILM NUMBER: 23730248 MAIL ADDRESS: STREET 1: 1111 BAGBY STREET 2: SKY LOBBY 2 CITY: HOUSTON STATE: TX ZIP: 77002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EOG RESOURCES INC CENTRAL INDEX KEY: 0000821189 STANDARD INDUSTRIAL CLASSIFICATION: CRUDE PETROLEUM & NATURAL GAS [1311] IRS NUMBER: 470684736 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1111 BAGBY, SKY LOBBY 2 CITY: HOUSTON STATE: TX ZIP: 77002 BUSINESS PHONE: 7136517000 MAIL ADDRESS: STREET 1: 1111 BAGBY, SKY LOBBY 2 CITY: HOUSTON STATE: TX ZIP: 77002 FORMER COMPANY: FORMER CONFORMED NAME: ENRON OIL & GAS CO DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-10 0 0000821189 EOG RESOURCES INC EOG 0001724997 Yacob Ezra Y 1111 BAGBY, SKY LOBBY 2 HOUSTON TX 77002 1 1 0 0 Chairman & CEO Common Stock 2023-03-10 4 M 0 15870 96.29 A 126039.357 D Common Stock 2023-03-10 4 D 0 13410 113.96 D 112629.357 D Common Stock 2023-03-10 4 F 0 968 113.96 D 111661.357 D Common Stock 2023-03-10 4 M 0 9029 75.09 A 120690.357 D Common Stock 2023-03-10 4 D 0 5950 113.96 D 114740.357 D Common Stock 2023-03-10 4 F 0 1212 113.96 D 113528.357 D Common Stock 2023-03-10 4 M 0 6013 37.44 A 119541.357 D Common Stock 2023-03-10 4 D 0 1976 113.96 D 117565.357 D Common Stock 2023-03-10 4 F 0 1589 113.96 D 115976.357 D Common Stock 2023-03-10 4 M 0 3190 49.86 A 119166.357 D Common Stock 2023-03-10 4 D 0 1396 113.96 D 117770.357 D Common Stock 2023-03-10 4 F 0 706 113.96 D 117064.357 D Common Stock 2023-03-10 4 M 0 12725 81.81 A 129789.357 D Common Stock 2023-03-10 4 D 0 9136 113.96 D 120653.357 D Common Stock 2023-03-10 4 F 0 1412 113.96 D 119241.357 D Stock Appreciation Rights 96.29 2023-03-10 4 M 0 15870 0.00 D 2018-09-25 2024-09-25 Common Stock 15870 0 D Stock Appreciation Rights 75.09 2023-03-10 4 M 0 9029 0.00 D 2020-09-26 2026-09-26 Common Stock 9029 0 D Stock Appreciation Rights 37.44 2023-03-10 4 M 0 6013 0.00 D 2021-09-28 2027-09-28 Common Stock 6013 3016 D Stock Appreciation Rights 49.86 2023-03-10 4 M 0 3190 0.00 D 2022-01-04 2028-01-04 Common Stock 3190 1600 D Stock Appreciation Rights 81.81 2023-03-10 4 M 0 12725 0.00 D 2022-09-27 2028-09-27 Common Stock 12725 25489 D The SARs granted became exercisable in increments of 33%, 33% and 34% on each of the first three anniversaries, respectively, of the September 25, 2017 date of grant. The SARs granted became fully exercisable on September 25, 2020. This exercise did not involve any open-market sale of the Issuer's Common Stock. The SARs granted became exercisable in increments of 33%, 33% and 34% on each of the first three anniversaries, respectively, of the September 26, 2019 date of grant. The SARs granted became fully exercisable on September 26, 2022. This exercise did not involve any open-market sale of the Issuer's Common Stock. The SARs granted become exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 28, 2020 date of grant. The SARs granted will become fully exercisable on September 28, 2023. This exercise did not involve any open-market sale of the Issuer's Common Stock. The SARs granted become exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the January 4, 2021 date of grant. The SARs granted will become fully exercisable on January 4, 2024. This exercise did not involve any open-market sale of the Issuer's Common Stock. The SARs granted become exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 27, 2021 date of grant. The SARs granted will become fully exercisable on September 27, 2024. This exercise did not involve any open-market sale of the Issuer's Common Stock. Christina K. Byrom, attorney-in-fact for Ezra Y. Yacob 2023-03-14